DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets has announced the addition of the "Global Insomnia Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Insomnia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Insomnia market. It covers active Insomnia pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Topics Covered:
1. Insomnia - Disease Overview
2. Insomnia Pipeline Overview
3. Insomnia Phase 3 Clinical Trial Pipeline Insights
4. Insomnia Phase 2 Clinical Trial Pipeline Insights
5. Insomnia Phase 1 Clinical Trial Pipeline Insights
6. Insomnia Preclinical Research Pipeline Insights
7. Insomnia Discovery Stage Pipeline Insights
8. Insomnia Drug Development Activities - Geographic Landscape
8.1. Insomnia R&D Activities in North America
8.2. Insomnia R&D Activities in Europe
9. Insomnia Pipeline - Licensing Activities
Table 1. Insomnia Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Insomnia Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Insomnia Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Insomnia Pipeline Molecules - Preclinical Research
Table 5. Insomnia Pipeline Molecules - Drug Discovery
Table 6. Insomnia R&D Activities by Geography
Table 7. Insomnia Pipeline Molecules - North America
Table 8. Insomnia Pipeline Molecules - Europe
Table 9. Insomnia Pipeline - Licensing Activities
Figure 1. Insomnia Pipeline Molecules by R&D Stage
Figure 2. Insomnia R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/m3ltdm/global_insomnia